Awesome read
@rusty02now I know we all have been saying a buyout of a drug or suite of drugs is the most likely outcome, phase 3 depending.
but I would at least want the sp to appreciate a decent amount from here before that hopefully eventuates.
Out of curiosity has anyone got any info on companies that had. A drug or company itself bought out at a really low market cap (ie where we are atm) and still went for big $$$ based on drug potential or did sp appreciate to a closer figure of the buyout price.
I am just thinking say we get to 50-60cents by end of phase 3 that puts our market cap as a whole company at around $1.3-4 billion. I just can’t see a say 5-7bil buyout happening unless as a company we were at roughly 2-3 billion.
The drug itself may have a huge market cap potential but unless we are basically about to start producing and selling I just don’t see that dream eventuating. I a more than happy to obviously be proved wrong…I mean I hope people can shed light on other companies and what happened to be honest.
hope everyone had a good weekend nonetheless
